Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Yoshio Marumoto
A Case of Chronic Hepatitis C, Genotype 3b Relapsed After Interferon Monotherapy, Treated With Pegylated Interferon Plus Ribavirin and Achieved Sustained Virological Response
Acta Hepatologica Japonica
Hepatology
Related publications
Non-Invasive Fibrosis Assessment Predicts Sustained Virological Response to Telaprevir With Pegylated Interferon and Ribavirin for Chronic Hepatitis C
Antiviral Therapy
Infectious Diseases
Pharmacology
Sustained Virologic Response and IL28B Single-Nucleotide Polymorphisms in Patients With Chronic Hepatitis C Treated With Pegylated Interferon Alfa and Ribavirin.
Acta Biochimica Polonica
Biochemistry
Genetics
Molecular Biology
Depressive Episode Incidence in Patients With Chronic Hepatitis C Treated With Pegylated Interferon and Ribavirin
Arquivos de Gastroenterologia
Gastroenterology
Re-Treatment With Interferon Plus Ribavirin of Chronic Hepatitis C Nonresponders to Interferon Monotherapy: A Meta-Analysis of Individual Patient Data
Digestive and Liver Disease
Hepatology
Gastroenterology
Interferon-Ë Rs12979860CC Genotype Predicts Sustained Virological Response to Therapy in Patients With Chronic Hepatitis C Genotype 4 but Enhances Hepatic Fibrosis
Medical Journal of Viral Hepatitis
Decrease in Regulatory T-Cell Function in Chronic Hepatitis C Patients Receiving Pegylated-Interferon Plus Ribavirin
International Journal of Infectious Diseases
Medicine
Infectious Diseases
Microbiology
Pegylated Interferon and Ribavirin Combination Therapy for Chronic Hepatitis C Associated With Thyroid Dysfunction
Acta Hepatologica Japonica
Hepatology
Sofosbuvir, Ribavirin and Pegylated Interferon for a Daclatasvir-Resistent Genotype 3 Hepatitis C Virus: Case Report and Review
Revista do Instituto de Medicina Tropical de Sao Paulo
Medicine
Infectious Diseases
Oxidative Stress and Antioxidant Defense in Patients With Chronic Hepatitis C Patients Before and After Pegylated Interferon Alfa-2b Plus Ribavirin Therapy
Journal of Translational Medicine
Biochemistry
Medicine
Genetics
Molecular Biology